Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours?

Cancer Treatment Reviews
E Marleen KemperOlaf van Tellingen

Abstract

Systemically administered chemotherapy is not very effective in the treatment of primary or metastatic brain tumours. An important reason for this low efficacy is insufficient drug delivery to the tumour site due to the presence of the blood-brain barrier (BBB). In this review, we give an overview of strategies that were tested to bypass the BBB or to increase its permeability for anticancer drugs. Local drug administration through intracerebral implants offers only little benefit to patients with brain tumours, probably due to the limited diffusion of the drugs in brain tissue. Temporary disruption of the BBB can be achieved with intracarotid infusions of hypertonic mannitol. This method has been used with some success; however, toxic side effects and the high complexity of the surgical procedure limit its usefulness. More recently, the use of the bradykinin agonist cereport was shown to be useful in preclinical studies, but unfortunately clinical studies did not show improved efficacy. Since P-glycoprotein in the BBB restricts the brain entry of many anticancer drugs, inhibition of this drug transporter may be an option for improved drug delivery to brain tumours. Pre-clinical studies have shown the feasibility to enhance the...Continue Reading

References

Nov 11, 1976·Biochimica Et Biophysica Acta·R L Juliano, V Ling
Sep 1, 1990·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·C Cordon-CardoM R Melamed
Apr 1, 1988·Annals of Neurology·J G Cairncross, D R Macdonald
Dec 15, 1973·The Journal of Comparative Neurology·M W BrightmanE Westergaard
Jan 1, 1995·Cancer Investigation·M T HuizingJ H Beijnen
Feb 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·A NadalP A McNaughton
Feb 1, 1993·Journal of Neuro-oncology·W BoogerdG Baris
Nov 1, 1995·Glia·K H Plate, W Risau
Jul 17, 1996·Journal of the National Cancer Institute·J van AsperenO van Tellingen
Mar 1, 1997·Journal of Neurosurgery·D L Silbergeld, M R Chicoine
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·A H SchinkelP Borst
Jan 1, 1997·Cancer Chemotherapy and Pharmacology·B I SikicG Chen
Mar 17, 1998·Biochemical and Biophysical Research Communications·H Huai-YunD W Miller
Apr 15, 1999·Annual Review of Neuroscience·L L Rubin, J M Staddon
Jan 12, 2000·Anti-cancer Drugs·S M AshmoreJ L Darling
Jun 6, 2000·Advanced Drug Delivery Reviews· de Lange ECD D Breimer
Dec 13, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·P J GaillardD D Breimer
Jan 5, 2001·Cancer Treatment Reviews·C NiederM Molls
Jan 11, 2001·The New England Journal of Medicine·L M DeAngelis
Feb 1, 2003·Lancet·Anthony BehinJean-Yves Delattre

❮ Previous
Next ❯

Citations

Jun 20, 2006·European Archives of Psychiatry and Clinical Neuroscience·Norbert Thuerauf, Martin Friedrich Fromm
Jan 12, 2011·Journal of Neuro-oncology·Seung-Kuk BaekHenry Hirschberg
Jan 10, 2013·Clinical Pharmacokinetics·Miroslav DostalekManoranjenni Chetty
Aug 8, 2008·Expert Reviews in Molecular Medicine·Joshua C AndersonCandece L Gladson
Jul 19, 2005·Nature Reviews. Neuroscience·Wolfgang Löscher, Heidrun Potschka
Jan 2, 2007·Topics in Magnetic Resonance Imaging : TMRI·Marco EssigFrederik L Giesel
May 2, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Soumyajit MajumdarRamesh Srirangam
May 1, 2008·The AAPS Journal·Marc-André BellavanceDavid Fortin
Jul 21, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Mark MuziJashvant D Unadkat
May 20, 2006·Neurosurgical Focus·William A VandergriftAbhay K Varma
Dec 1, 2009·Future Medicinal Chemistry·David D StenehjemGrant W Anderson
Sep 3, 2013·Pharmaceutical Research·Linfeng WuTao L Lowe
Jun 9, 2006·Expert Review of Anticancer Therapy·Patrick Y WenJan Drappatz
Jun 12, 2013·Expert Opinion on Drug Delivery·Ann-Marie ChackoVladimir Muzykantov
Sep 8, 2009·Expert Opinion on Drug Delivery·Valentino LaquintanaGiuseppe Trapani
Jun 23, 2011·Journal of Drug Targeting·Werner GeldenhuysVijaykumar Sutariya
Jul 17, 2009·Expert Opinion on Investigational Drugs·Otto Metzger-FilhoAwada Ahmad
Oct 31, 2007·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·S OswaldH K Kroemer
Mar 10, 2016·Materials Science & Engineering. C, Materials for Biological Applications·Katarzyna Krukiewicz, Jerzy K Zak
Oct 24, 2012·Magnetic Resonance Imaging Clinics of North America·Marco EssigJuan E Gutierrez
Dec 14, 2011·Advanced Drug Delivery Reviews·Yan Chen, Lihong Liu
Jun 25, 2010·International Journal of Pharmaceutics·Marc-André BellavanceDavid Fortin
Jan 21, 2015·Biochemical and Biophysical Research Communications·Li-Bo LiuPing Wang
Dec 19, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Silvio Garattini
Apr 26, 2006·Journal of Clinical Pharmacy and Therapeutics·R B RaffaH-F Jen Weng
Oct 19, 2006·Annals of Neurology·Dirk M HermannClaudio L Bassetti
Oct 10, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E M KemperO van Tellingen
Dec 2, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Grace H HuynhFrancis C Szoka
Jul 14, 2005·Progress in Neurobiology·Wolfgang Löscher, Heidrun Potschka
Aug 9, 2005·Hematology/oncology Clinics of North America·Carole SoussainNancy D Doolittle
Jun 23, 2005·European Journal of Pharmacology·Milos MarkovićDjordje Miljković

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Blood-Brain Barrier Transport in Neurodegeneration

The blood brain barrier is important for regulating the movement of biomolecules in and out of the brain. For example, membrane transporters in the blood brain barrier can be essential for regulating drug movement and dysregulation of these processes may play a role in neurodegeneration. This feed follows the latest research on this topic.

© 2022 Meta ULC. All rights reserved